IRX Therapeutics Receives $2,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4355c695-a433-4138-9b82-ff0612e62b65
Date
5/13/2016
Company Name
IRX Therapeutics
Mailing Address
140 West 57th Street New York, NY 10019 USA
Company Description
IRX Therapeutics’ mission is to discover and commercialize drugs that stimulate a coordinated TH1-specific cellular immune response to treat human diseases. This immune response is essential for the eradication of most viruses and tumors, and relies on the effective functioning of dendritic cells, macrophages, and T-cells.
Website
http://www.irxtherapeutics.com
Transaction Type
Debt
Transaction Amount
$2,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 1 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed